+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Delcath Systems Inc (DCTH) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Delcath Systems Inc (DCTH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Delcath Systems Inc (Delcath) specializes in developing percutaneous hepatic perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of chemotherapeutic agents to the liver, while preventing them from entering the patient's bloodstream. The company’s lead product Melphalan Hydrochloride for Injection for use with the proprietary Delcath Hepatic Delivery System (HEPZATO KIT) to administer high dose chemotherapy to the liver. The company sells its proprietary system to deliver and filter melphalan hydrochloride in Europe under the trade name, Delcath Chemosat Hepatic Delivery System for Melphalan (Chemosat). Delcath is headquartered in New York, the US.

Delcath Systems Inc Key Recent Developments

Nov 08, 2022: Delcath Systems Reports Third Quarter 2022 Results and Provides Business Update
Oct 24, 2022: Delcath Systems to Host Third Quarter 2022 Results
Aug 08, 2022: Delcath Systems Reports Second Quarter 2022 Results and Provides Business Update
Jul 27, 2022: Delcath Systems to Present at Upcoming Investor Conferences in August
Jul 27, 2022: Delcath Systems to Host Second Quarter 2022 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Delcath Systems Inc - Key Facts
  • Delcath Systems Inc - Key Employees
  • Delcath Systems Inc - Key Employee Biographies
  • Delcath Systems Inc - Major Products and Services
  • Delcath Systems Inc - History
  • Delcath Systems Inc - Company Statement
  • Delcath Systems Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Delcath Systems Inc - Business Description
  • Business Segment: Other Revenue
  • Performance
  • Business Segment: Product Revenue
  • Performance
  • R&D Overview
  • Delcath Systems Inc - Corporate Strategy
  • Delcath Systems Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Delcath Systems Inc - Strengths
  • Delcath Systems Inc - Weaknesses
  • Delcath Systems Inc - Opportunities
  • Delcath Systems Inc - Threats
  • Delcath Systems Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Delcath Systems Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 08, 2022: Delcath Systems Reports Third Quarter 2022 Results and Provides Business Update
  • Oct 24, 2022: Delcath Systems to Host Third Quarter 2022 Results
  • Aug 08, 2022: Delcath Systems Reports Second Quarter 2022 Results and Provides Business Update
  • Jul 27, 2022: Delcath Systems to Present at Upcoming Investor Conferences in August
  • Jul 27, 2022: Delcath Systems to Host Second Quarter 2022 Results
  • May 09, 2022: Delcath Announces Poster Presentation at the 2022 ASCO Annual Meeting
  • Feb 07, 2022: Delcath Appoints Anthony Dias as its new Vice President of Finance; Inducement Grant Reported
  • Nov 09, 2021: Delcath Systems Announces Third Quarter 2021 Results
  • Aug 10, 2021: Delcath Systems Announces Second Quarter 2021 Results
  • Jul 28, 2021: Delcath Systems Schedules Conference Call to Report 2021 Second Quarter Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Delcath Systems Inc, Key Facts
  • Delcath Systems Inc, Key Employees
  • Delcath Systems Inc, Key Employee Biographies
  • Delcath Systems Inc, Major Products and Services
  • Delcath Systems Inc, History
  • Delcath Systems Inc, Other Locations
  • Delcath Systems Inc, Subsidiaries
  • Delcath Systems Inc, Key Competitors
  • Delcath Systems Inc, Annual Ratios
  • Delcath Systems Inc, Interim Ratios
  • Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Delcath Systems Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Delcath Systems Inc, Performance Chart (2017 - 2021)
  • Delcath Systems Inc, Ratio Charts
  • Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Delcath Systems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Biocompatibles Inc.
  • AngioDynamics Inc
  • Sirtex Medical Ltd
  • CeloNova BioSciences Inc
  • Genentech USA Inc
  • GlaxoSmithKline AG